| RS2512386646 |
LONP1
|
Health Risk |
Pathogenic |
LONP1-related disorder, LONP1-related disorder |
| RS2512389876 |
INSR
|
Health Risk |
Likely pathogenic |
46, XY disorder of sex development |
| RS2512401555 |
TYK2
|
Health Risk |
Likely pathogenic |
Immunodeficiency 35, Immunodeficiency 35 |
| RS2512409407 |
LONP1
|
Health Risk |
Likely pathogenic |
LONP1-related disorder, LONP1-related disorder |
| RS2512412601 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512412871 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512413096 |
LDLR
|
Health Risk |
Pathogenic |
Homozygous familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512413189 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512413340 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512415167 |
LONP1
|
Health Risk |
Likely pathogenic |
LONP1-related disorder, LONP1-related disorder |
| RS2512415212 |
LONP1
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2512415881 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512416149 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512416446 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512416505 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512416741 |
LDLR
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypercholesterolemia, familial |
| RS2512416749 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512416887 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512417016 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Familial hypercholesterolemia |
| RS2512417179 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512420115 |
PIGN
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512420239 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512420710 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512421362 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512423018 |
GIPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 15, Inborn genetic diseases |
| RS2512423085 |
GIPC3
|
Health Risk |
Likely pathogenic |
GIPC3-related disorder, GIPC3-related disorder |
| RS2512423093 |
PIGN
|
Health Risk |
Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512427980 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512428555 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512429091 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512429111 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512429190 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512429344 |
LDLR
|
Health Risk |
Likely pathogenic |
Homozygous familial hypercholesterolemia, Homozygous familial hypercholesterolemia |
| RS2512429887 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512430551 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypercholesterolemia |
| RS2512431262 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512431281 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512431409 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512431448 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512439870 |
HCN2
|
Health Risk |
Pathogenic |
HCN2 related developmental and epileptic encephalopathy, HCN2 related developmental and epileptic encephalopathy |
| RS2512441003 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512441961 |
LDLR
|
Health Risk |
Likely pathogenic |
Homozygous familial hypercholesterolemia, Homozygous familial hypercholesterolemia |
| RS2512443872 |
LONP1
|
Health Risk |
Pathogenic |
— |
| RS2512444496 |
CLPP
|
Health Risk |
Pathogenic |
Perrault syndrome 1, Perrault syndrome 1 |
| RS2512444516 |
PIGN
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512445672 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS2512446194 |
ARHGEF18
|
Health Risk |
Pathogenic |
— |
| RS2512446307 |
CLPP
|
Health Risk |
Pathogenic |
— |
| RS2512449193 |
HCN2
|
Health Risk |
Pathogenic |
HCN2 related developmental and epileptic encephalopathy, HCN2 related developmental and epileptic encephalopathy |
| RS2512450547 |
HCN2
|
Health Risk |
Pathogenic |
HCN2 related developmental and epileptic encephalopathy, HCN2 related developmental and epileptic encephalopathy |
| RS2512452816 |
HCN2
|
Health Risk |
Pathogenic |
HCN2 related developmental and epileptic encephalopathy, HCN2 related developmental and epileptic encephalopathy |
| RS2512454201 |
TYK2
|
Health Risk |
Pathogenic |
Immunodeficiency 35, Immunodeficiency 35 |
| RS2512454602 |
HCN2
|
Health Risk |
Pathogenic |
HCN2 related developmental and epileptic encephalopathy, HCN2 related developmental and epileptic encephalopathy |
| RS2512455727 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512455976 |
LDLR
|
Health Risk |
Likely pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512459304 |
HCN2
|
Health Risk |
Pathogenic |
HCN2 related developmental and epileptic encephalopathy, HCN2 related developmental and epileptic encephalopathy |
| RS2512460552 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512461138 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Familial hypercholesterolemia |
| RS2512461322 |
LDLR
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512461325 |
TYK2
|
Health Risk |
Pathogenic |
Immunodeficiency 35, Immunodeficiency 35 |
| RS2512461637 |
LDLR
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2512463430 |
APC2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal recessive 74 |
| RS2512466186 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512466411 |
LDLR
|
Health Risk |
Likely pathogenic |
Hypercholesterolemia, familial |
| RS2512468099 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, MCOLN1-related disorder |
| RS2512468178 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512468209 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512469342 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512469706 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512469807 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512469818 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512469840 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512470541 |
MCOLN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512470594 |
MCOLN1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2512470634 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512470983 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512471493 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512471532 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512472276 |
MCOLN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucolipidosis type IV, Lisch epithelial corneal dystrophy |
| RS2512472317 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512472667 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512472676 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512472704 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512473619 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512473911 |
ODAD3
|
Health Risk |
Likely pathogenic |
ODAD3-related disorder, ODAD3-related disorder |
| RS2512474273 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512474342 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512474348 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512474534 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512475700 |
APC2
|
Health Risk |
Likely pathogenic |
Cortical dysplasia, complex |
| RS2512477210 |
BPTF
|
Health Risk |
Likely pathogenic |
— |
| RS2512477841 |
MCOLN1
|
Health Risk |
Pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS2512478127 |
RNASEH2A
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi-Goutieres syndrome 4 |
| RS2512479908 |
RNASEH2A
|
Health Risk |
Likely pathogenic |
RNASEH2A-related disorder, RNASEH2A-related disorder |
| RS2512481936 |
ATG4D
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2512482280 |
ODAD3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 30, Primary ciliary dyskinesia 30 |
| RS2512482311 |
ODAD3
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 30, Primary ciliary dyskinesia 30 |
| RS2512483025 |
ODAD3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 30, Primary ciliary dyskinesia 30 |
| RS2512483255 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS2512484262 |
MAN2B1
|
Health Risk |
Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |